← QuidelOrtho Corp
| Annual Trend | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Operating Revenue | $1.7b | $3.3b | $3.0b | $2.8b | $2.7b | |
| Total Revenue | $1.7b | $1.7b | $3.0b | $2.8b | $2.7b | |
| Revenue from Contract with Customer, Including Assessed Tax | — | $1.7b | $3.0b | — | — | |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | $601.4m | $420.3m | $1.5b | $1.5b | $1.5b | |
| Operating expenses: | ||||||
| EBIT | $810.4m | $149.8m | ($1.9b) | ($924.6m) | ||
| Operating Income | — | $982.5m | $257.0m | $45.8m | $54.8m | |
| Operating Income (Loss) | $1.1b | $906.0m | $139.1m | ($2.0b) | ($919.2m) | |
| Total Operating Income As Reported | — | $843.7m | $139.1m | ($2.0b) | ($919.2m) | |
| Additional Financial Items | ||||||
| Amortization of Intangible Assets | $27.3m | $27.4m | $204.8m | $203.4m | $189.2m | |
| Capitalized Computer Software, Amortization | — | $1.0m | $600k | $2.7m | $3.6m | |
| Goodwill, Impairment Loss | — | — | — | $1.8b | $700.7m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $1.0b | $891.2m | ($163.9m) | ($2.2b) | ($523.8m) | |
| Income (Loss) from Equity Method Investments | — | $1.5m | ($3.6m) | $700k | $2.5m | |
| Interest Income, Other | — | $300k | $5.5m | $2.6m | $2.2m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $1.0b | $900.3m | ($29.1m) | ($2.1b) | ($1.1b) | |
| Net Income Common Stockholders | — | $548.7m | ($10.1m) | ($2.1b) | ($1.1b) | |
| Net Income | — | $548.7m | ($10.1m) | ($2.1b) | ($1.1b) | |
| Net Income (Loss) Attributable to Parent | — | $704.2m | ($10.1m) | ($2.1b) | ($1.1b) | |
| Earnings Per Share, Basic | $19.24 | $16.74 | ($0.15) | ($30.54) | ($16.69) | |
| Earnings Per Share, Diluted | $18.60 | $16.43 | ($0.15) | ($30.54) | ($16.69) | |
| Weighted Average Number of Shares Outstanding, Basic | 42.1m | 42.1m | 66.8m | 67.2m | 67.8m | |
| Weighted Average Number of Shares Outstanding, Diluted | 43.6m | 42.9m | 66.8m | 67.2m | 67.8m | |
| Research and Development Expense | — | $95.7m | $246.8m | $218.7m | $186.2m | |
| Selling, General and Administrative Expense | — | $239.6m | $763.2m | $766.8m | $746.3m | |
| Other Nonoperating Income (Expense) | — | $100k | ($20.6m) | ($7.1m) | ($5.8m) | |
| Interest Expense (non-operating) | — | $74.5m | $178.9m | $163.5m | $177.6m | |
| Business Combination, Acquisition Related Costs | — | $9.6m | $113.4m | $127.2m | — | |
| Current Income Tax Expense (Benefit) | — | $193.5m | ($14.5m) | $25.9m | $24.0m | |
| Other Cost and Expense, Operating | — | $0 | $27.1m | $51.8m | $97.7m | |
| Income Tax Expense (Benefit) | — | $196.1m | ($19.0m) | ($79.5m) | $24.1m | |
| Interest Income (Expense), Net | — | ($5.8m) | ($147.6m) | ($163.5m) | — | |
| Interest Income (Expense), Nonoperating, Net | — | — | — | ($163.5m) | ($177.6m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.